Erythromelalgia Caused by Polycythemia Vera Combined with Primary Aldosteronism.
Erythromelalgia
polycythemia vera
primary aldosteronism
Journal
European journal of case reports in internal medicine
ISSN: 2284-2594
Titre abrégé: Eur J Case Rep Intern Med
Pays: Italy
ID NLM: 101648453
Informations de publication
Date de publication:
2020
2020
Historique:
received:
29
06
2020
accepted:
13
07
2020
entrez:
16
11
2020
pubmed:
17
11
2020
medline:
17
11
2020
Statut:
epublish
Résumé
A 61-year-old woman with a history of primary aldosteronism caused by unilateral hyperplasia of the adrenal gland presented with a 2-week history of redness and severe pain in the right thumb and thenar regions. She had initially visited a dermatologist and was diagnosed with cellulitis and treated with cefditoren pivoxil for 5 days, but there was no improvement. The pain worsened and was accompanied by a burning sensation. The dermatologist prescribed famciclovir for 5 days owing to suspicion of herpes zoster. The patient was then referred to our department because her symptoms persisted. Physical examination showed no abnormalities other than the redness in the right thumb and thenar regions and spontaneous moderate pain present throughout the right thumb. Investigations revealed normal blood chemistry and coagulation factor levels, except for elevated haemoglobin (18.2 g/dl). Further investigations revealed an erythropoietin level of 2.3 IU/ml and Janus kinase 2 mutation. Hence, we diagnosed the patient with erythromelalgia caused by polycythemia vera. In this report, we discuss the treatment of polycythemia causing erythromelalgia, and the aetiology of primary aldosteronism and polycythemia vera. Polycythemia can cause erythromelalgia, which should be treated with aspirin.Primary aldosteronism causes secondary erythropoiesis through activation of the renin-aldosterone system, but the mechanism is not clear.Erythropoiesis may be promoted by concurrent primary aldosteronism and polycythemia vera, resulting in secondary erythromelalgia.
Identifiants
pubmed: 33194862
doi: 10.12890/2020_001852
pii: 1852-1-15724-1-10-20200810
pmc: PMC7654995
doi:
Types de publication
Journal Article
Langues
eng
Pagination
001852Informations de copyright
© EFIM 2020.
Déclaration de conflit d'intérêts
Conflicts of Interests: The Authors declare that there are no competing interests.
Références
J Am Acad Dermatol. 2000 Nov;43(5 Pt 1):841-7
pubmed: 11050591
FASEB J. 2005 Dec;19(14):2023-5
pubmed: 16223784
Cancer Biol Ther. 2007 Sep;6(9):1434-6
pubmed: 17873518
Nature. 1995 May 18;375(6528):247-50
pubmed: 7746328
Am J Hematol. 2012 Mar;87(3):285-93
pubmed: 22331582